Complement Dysfunction News Today

Positive Data Presented at Recent European Congress; Additional Forthcoming Data to be Presented at US Healthcare Conference.CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aviceda Therapeutics, a privately held, late-stage clinical biotech company focused on developing next-generation immunomodulators by harnessing the power of...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep 25, 2023--

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aviceda Therapeutics, a private biotech company focused on developing the next generation immuno-modulators by harnessing the power of glycobiology to modulate the innate immune system and alleviate chronic, non-resolving inflammation, today announced their upcoming oral and poster...